Data as of Jan 30
| -0.51 / -0.98%|
The 7 analysts offering 12-month price forecasts for Abiomed Inc have a median target of 56.00, with a high estimate of 62.00 and a low estimate of 38.00. The median estimate represents a +8.23% increase from the last price of 51.74.
The current consensus among 10 polled investment analysts is to Hold stock in Abiomed Inc. This rating has held steady since January, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.